| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AEW541 | CCLE | pan-cancer | AAC | -0.12 | 0.009 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.082 | 0.01 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | TG-101348 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.01 |